Maintaining serum glucose ≤180 mg/dL with continuous insulin infusions in patients with and without diabetes mellitus reduces morbidity and mortality, lowers the incidence of sternal wound infections, reduces hospital length of stay, and enhances long-term survival. The gene discussed is INS; the disease is diabetes mellitus.